Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PRLD
#2987
Prelude Therapeutics Incorporated
2.7
6
-5.80%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-5.80%
Monthly Change
+28.37%
6 month change
+113.95%
Year Change
+253.85%
Previous Close
2.9
3
Open
2.7
6
Bid
Ask
Low
2.7
6
High
2.7
6
Volume
3
Markets
US Stock Market
Healthcare
PRLD
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
Prelude Therapeutics stock gets reiterated Market Outperform rating at Citizens
Prelude Therapeutics stock surges after FDA clears IND for cancer drug
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Earnings call transcript: Prelude Therapeutics Q3 2025 sees stock steadiness
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.56%
Palantir, Shopify among market cap stock movers on Tuesday
Palantir, Uber among market cap stock movers on Tuesday
Prelude Therapeutics stock climbs after exclusive JAK2 option deal with Incyte
Prelude Therapeutics shifts focus to JAK2 and KAT6A programs